Literature DB >> 23794481

Virus infections among young children--the first year of the INDIS study.

Marja-Leena Simonen-Tikka1, Päivi Klemola, Sointu Suomenrinne, Svetlana Kaijalainen, Daniela Söderström, Carita Savolainen-Kopra, Kirsti Näntö-Salonen, Jorma Ilonen, Tuula Simell, Olli Simell, Merja Roivainen.   

Abstract

The frequencies of early childhood infections were studied in healthy children with increased genetic risk for type 1 diabetes participating in the ongoing prospective high intensive infection follow-up Study, INDIS, started in 2009 in Turku, Finland. Here the results obtained from 160 stool to 160 nasal swab specimens collected in parallel at times of infectious symptoms in 2009-2010 from 45 children at the age of 24 months or younger are reported. The specimens were analyzed for enteric (human enterovirus, norovirus, rotavirus, sapovirus, astrovirus) and respiratory RNA viruses (human enterovirus and rhinovirus) common in early childhood, respectively, using highly validated virus-specific real-time PCR methods. According to the results 96% of the children had at least one virus infection during the study period and one or several viral agents were detected in 76% of sample sets. The most prevalent viral agents were human rhinovirus, enterovirus, parechovirus, and norovirus (genotype GII) with positive specimens 57.5%, 28.8%, 19.4%, and 6.9%, respectively. Other intestinal viruses were found in less than 2% of stool specimens. Single infections covered 40.0% of the specimens while multiple infections with two or more infectious agents were detected in 36.3% of specimens and altogether 11 combinations of viruses were included in the mixed infections. Although human enterovirus is known to be a frequent finding in stool specimens, especially during early childhood, it was found in this study more frequently in nasal swab specimens. Whether this is true, more general, in countries with the high hygiene level remains to be shown.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  childhood; type 1 diabetes; virus infection

Mesh:

Year:  2013        PMID: 23794481     DOI: 10.1002/jmv.23625

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

Review 1.  Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.

Authors:  Aaron Michels; Li Zhang; Anmar Khadra; Jake A Kushner; Maria J Redondo; Massimo Pietropaolo
Journal:  Pediatr Diabetes       Date:  2015-07-23       Impact factor: 4.866

2.  Absence of genetic differences among G10P[11] rotaviruses associated with asymptomatic and symptomatic neonatal infections in Vellore, India.

Authors:  Margaret H Libonati; Allison F Dennis; Sasirekha Ramani; Sarah M McDonald; Asmik Akopov; Ewen F Kirkness; Gagandeep Kang; John T Patton
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

3.  Saffold Virus, a Human Cardiovirus, and Risk of Persistent Islet Autoantibodies in the Longitudinal Birth Cohort Study MIDIA.

Authors:  German Tapia; Håkon Bøås; Eric J de Muinck; Ondrej Cinek; Lars C Stene; Peter A Torjesen; Trond Rasmussen; Kjersti S Rønningen
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

Review 4.  Epidemiology of Classic and Novel Human Astrovirus: Gastroenteritis and Beyond.

Authors:  Diem-Lan Vu; Albert Bosch; Rosa M Pintó; Susana Guix
Journal:  Viruses       Date:  2017-02-18       Impact factor: 5.048

5.  Specific probiotics and virological findings in symptomatic conscripts attending military service in Finland.

Authors:  Liisa Lehtoranta; Kim Kalima; Liang He; Maija Lappalainen; Merja Roivainen; Mervi Närkiö; Mika Mäkelä; Simo Siitonen; Riitta Korpela; Anne Pitkäranta
Journal:  J Clin Virol       Date:  2014-04-13       Impact factor: 3.168

6.  High prevalence of selected viruses and parasites and their predictors in Malawian children.

Authors:  Y-M Fan; S Oikarinen; K-M Lehto; N Nurminen; R Juuti; C Mangani; K Maleta; H Hyöty; P Ashorn
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.